Harlan Robins's most recent trade in Adaptive Biotechnologies Corp was a trade of 10,000 Common Stock done at an average price of $14.9 . Disclosure was reported to the exchange on April 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 08 Apr 2026 | 10,000 | 1,512,058 (1%) | 0% | 14.9 | 148,500 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 329,600 | 1,522,058 (1%) | 0% | 13.2 | 4,340,832 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 140,666 | 1,851,658 (1%) | 0% | 13.2 | 1,852,571 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 709,220 | 1,992,324 (1%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 127,813 | 1,283,104 (1%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 02 Mar 2026 | 14,233 | 1,155,291 (0%) | 0% | 16.5 | 235,129 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 02 Mar 2026 | 10,000 | 1,169,524 (0%) | 0% | 15.7 | 157,200 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.60 per share. | 02 Feb 2026 | 34,668 | 1,187,644 (0%) | 0% | 18.6 | 644,825 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 02 Feb 2026 | 8,120 | 1,179,524 (0%) | 0% | 19 | 154,280 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.44 per share. | 06 Jan 2026 | 10,000 | 1,222,312 (0%) | 0% | 16.4 | 164,400 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 03 Dec 2025 | 27,212 | 1,242,312 (0%) | 0% | 18.6 | 506,415 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.61 per share. | 03 Dec 2025 | 10,000 | 1,232,312 (0%) | 0% | 16.6 | 166,100 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.82 per share. | 10 Nov 2025 | 10,000 | 1,269,524 (1%) | 0% | 14.8 | 148,200 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 68,412 | 0 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.35 per share. | 01 May 2025 | 68,412 | 1,279,524 (1%) | 0% | 7.3 | 502,828 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 01 May 2025 | 68,412 | 1,347,936 (1%) | 0% | 6.3 | 432,364 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 24 Mar 2025 | 1,698 | 1,281,222 (1%) | 0% | 6.3 | 10,731 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 24 Mar 2025 | 1,698 | 1,279,524 (1%) | 0% | 9 | 15,282 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 1,698 | 68,412 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 355,000 | 1,376,180 (1%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 56,053 | 1,279,524 (1%) | 0% | 7.0 | 391,810 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,603 | 1,335,577 (1%) | 0% | 7.0 | 283,409 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 354,610 | 1,021,180 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 354,610 | 666,570 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 617,792 | 617,792 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 247,117 | 316,477 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 4,517 | 311,960 (0%) | 0% | 12.0 | 54,249 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.05 per share. | 17 Nov 2021 | 3,700 | 69,360 (0%) | 0% | 32.1 | 118,585 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 3,700 | 285,100 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Nov 2021 | 3,700 | 73,060 (0%) | 0% | 6.6 | 24,235 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 300 | 284,800 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.36 per share. | 17 Nov 2021 | 300 | 69,360 (0%) | 0% | 31.4 | 9,408 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Nov 2021 | 300 | 69,660 (0%) | 0% | 6.6 | 1,965 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 3,800 | 296,200 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 19 Oct 2021 | 3,800 | 73,160 (0%) | 0% | 6.6 | 24,890 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 19 Oct 2021 | 3,700 | 73,060 (0%) | 0% | 6.6 | 24,235 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 3,700 | 288,800 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 3,700 | 292,500 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.73 per share. | 19 Oct 2021 | 3,700 | 69,360 (0%) | 0% | 33.7 | 124,801 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.71 per share. | 19 Oct 2021 | 3,700 | 69,360 (0%) | 0% | 33.7 | 124,727 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 19 Oct 2021 | 3,700 | 73,060 (0%) | 0% | 6.6 | 24,235 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.76 per share. | 19 Oct 2021 | 3,500 | 69,360 (0%) | 0% | 33.8 | 118,160 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.91 per share. | 19 Oct 2021 | 300 | 72,860 (0%) | 0% | 32.9 | 9,873 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 3,895 | 74,005 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 3,895 | 77,900 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.96 per share. | 06 Oct 2021 | 3,895 | 69,360 (0%) | 0% | 33.0 | 128,379 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 06 Oct 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 06 Oct 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 06 Oct 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.27 per share. | 06 Oct 2021 | 3,895 | 69,360 (0%) | 0% | 32.3 | 125,692 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 3,895 | 70,110 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.68 per share. | 06 Oct 2021 | 3,695 | 69,360 (0%) | 0% | 33.7 | 124,448 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 06 Oct 2021 | 200 | 73,055 (0%) | 0% | 32.5 | 6,500 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 3,895 | 81,795 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 3,895 | 85,690 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 3,895 | 89,585 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 13 Sep 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 13 Sep 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 13 Sep 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 36.52 per share. | 13 Sep 2021 | 2,995 | 70,260 (0%) | 0% | 36.5 | 109,377 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 13 Sep 2021 | 2,995 | 70,260 (0%) | 0% | 37.4 | 111,983 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 36.49 per share. | 13 Sep 2021 | 2,795 | 70,460 (0%) | 0% | 36.5 | 101,990 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.36 per share. | 13 Sep 2021 | 1,100 | 69,360 (0%) | 0% | 37.4 | 41,096 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.89 per share. | 13 Sep 2021 | 900 | 69,360 (0%) | 0% | 37.9 | 34,101 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.23 per share. | 13 Sep 2021 | 900 | 69,360 (0%) | 0% | 37.2 | 33,507 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2021 | 3,895 | 105,165 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2021 | 3,895 | 109,060 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2021 | 3,895 | 112,955 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 19 Jul 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 19 Jul 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 19 Jul 2021 | 3,895 | 73,255 (0%) | 0% | 6.3 | 24,616 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.33 per share. | 19 Jul 2021 | 2,622 | 69,360 (0%) | 0% | 37.3 | 97,879 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 19 Jul 2021 | 2,595 | 69,360 (0%) | 0% | 37.8 | 98,143 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 38.11 per share. | 19 Jul 2021 | 2,495 | 69,360 (0%) | 0% | 38.1 | 95,084 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.29 per share. | 19 Jul 2021 | 1,400 | 71,855 (0%) | 0% | 37.3 | 52,206 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 36.81 per share. | 19 Jul 2021 | 1,300 | 71,955 (0%) | 0% | 36.8 | 47,853 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 36.70 per share. | 19 Jul 2021 | 1,273 | 71,982 (0%) | 0% | 36.7 | 46,719 | Common Stock |